What Is Pediatric Asthma?
Pediatric asthma is a chronic inflammatory disease of the airways characterized by recurrent episodes of wheezing, cough, dyspnea, and chest tightness, caused by reversible airflow obstruction and bronchial hyperresponsiveness. It is the most common chronic disease of childhood, affecting approximately 10-15% of children.
We know that watching your child struggle to breathe is one of the most distressing experiences for any parent. Asthma can generate fear — in the child as well as in the family. It is important to understand that, with appropriate treatment, most children with asthma can lead a fully normal life, including physical activity and participation in sports.
Childhood asthma has distinct phenotypes: the early transient wheezer (viral wheezing in children under 3 years, which often resolves), the persistent atopic wheezer (associated with atopy/allergy, with a higher likelihood of persisting), and mixed forms. The distinction influences prognosis and treatment.
Chronic Inflammation
Asthma is not just bronchospasm — it is a chronic inflammatory disease of the airways that requires ongoing preventive treatment, not only symptom relief.
Control Is Achievable
With appropriate treatment, most children achieve full asthma control and can lead a normal life, including physical activity without restrictions.
Partnership with the Family
Management of pediatric asthma depends on partnership among the healthcare team, parents, and child. Education about the disease is essential for control.
Pathophysiology
The pathophysiology of asthma involves a triad: chronic inflammation of the bronchial mucosa, airway hyperresponsiveness, and bronchial remodeling. In the atopic form (most common in childhood), the inflammatory cascade is mediated by Th2 lymphocytes.
Inhaled allergens (dust mites, fungi, animal dander, pollen) are captured by bronchial dendritic cells, which present the antigens to CD4+ T lymphocytes, polarizing the response toward the Th2 profile. Th2 cytokines (IL-4, IL-5, IL-13) promote: production of specific IgE (IL-4), recruitment and activation of eosinophils (IL-5), and mucus hypersecretion and bronchial hyperresponsiveness (IL-13).
IgE binds to bronchial mast cells which, on re-encountering the allergen, degranulate and release histamine, leukotrienes, and prostaglandins — causing acute bronchospasm, mucosal edema, and mucus production. The result is airflow obstruction that manifests as wheezing, cough, and breathing difficulty.
WHEEZING PHENOTYPES IN CHILDHOOD
| PHENOTYPE | AGE | ASSOCIATION | PROGNOSIS |
|---|---|---|---|
| Early transient wheezer | <3 years | Viral infections, smaller-caliber airways | Resolves by age 6 in most cases |
| Persistent atopic wheezer | > 3 years | Personal/family atopy, allergen sensitization | Higher likelihood of persistent asthma |
| Late-onset wheezer | > 6 years | Variable | May represent late onset of atopic asthma |
Symptoms
Symptoms of pediatric asthma are typically episodic and variable in intensity, with asymptomatic periods between flares. Common triggers include viral respiratory infections, physical exercise, allergens, cold air, emotions, and pollutants.
Manifestations of Pediatric Asthma
- 01
Wheezing (chest whistling)
High-pitched sound produced by air passage through narrowed airways. More audible on expiration. May be evident or audible only with a stethoscope.
- 02
Recurrent cough
Often nocturnal or at dawn. May be the only symptom (cough-variant asthma). Worsens with exercise, laughing, crying, or cold exposure.
- 03
Dyspnea (breathing difficulty)
Sensation of chest tightness and shortness of breath. In small children: intercostal retraction, nasal flaring, and difficulty nursing or feeding.
- 04
Exercise limitation
Cough, wheezing, or excessive fatigue during physical activity. Exercise-induced asthma may be the only manifestation.
- 05
Nocturnal worsening
Symptoms that wake the child during the night. Nocturnal worsening is a marker of uncontrolled asthma.
- 06
Seasonality
Worsening in certain seasons (autumn/winter from viruses; spring from pollen) or with weather changes.
Diagnosis
Diagnosis is based on a compatible clinical history and, in children over 6 years, on pulmonary function testing. Spirometry with bronchodilator testing is the reference exam: demonstration of reversible airflow obstruction (12% or greater increase in FEV1 after bronchodilator).
Complementary tests include skin prick test or specific IgE for allergens (to identify sensitizations), chest X-ray (to rule out differential diagnoses), and, in selected cases, bronchial provocation testing or measurement of fractional exhaled nitric oxide (FeNO) as a marker of eosinophilic inflammation.
DIAGNÓSTICO DIFERENCIAL
Diagnóstico Diferencial
Viral Bronchiolitis
First episode in an infant, usually RSV, no atopic family history
Upper Airway Cough Syndrome
Dry cough with postnasal drip, no wheezing, improves with decongestant
Airway Foreign Body
Sudden onset in a previously healthy child, unilateral wheezing or stridor
Laryngomalacia/Tracheomalacia
Inspiratory stridor present from birth, improves in prone position, absence of expiratory wheezing
Bronchopulmonary Dysplasia
History of prematurity and neonatal mechanical ventilation, chronic radiologic changes
Viral Bronchiolitis versus Asthma
Viral bronchiolitis, caused mainly by respiratory syncytial virus (RSV), is the most common cause of wheezing in infants and may be confused with asthma. The distinction matters because bronchiolitis typically affects children under 2 years, occurs in seasonal outbreaks, and is usually the first wheezing episode. Bronchiolitis does not respond to bronchodilators with the same efficacy as asthma, and treatment is primarily supportive.
However, multiple episodes of virus-associated wheezing, especially in children with a family history of atopy, may represent the early atopic wheezer phenotype — which has a high probability of progressing to persistent asthma. The physician should weigh the body of evidence to establish prognosis and the need for preventive treatment.
Airway Foreign Body
Foreign body aspiration should be considered in any child with sudden onset of wheezing or cough, especially in children under 3 years. Unlike asthma, foreign body wheezing tends to be unilateral, localized, and may be accompanied by atelectasis or unilateral hyperinflation on chest X-ray. A history of choking or sudden coughing fit is a key clinical clue.
Lack of response to bronchodilators is a warning sign. Rigid bronchoscopy is the diagnostic and therapeutic procedure of choice. Delay in diagnosis can lead to serious complications such as obstructive pneumonia and chronic atelectasis. In every child with sudden-onset wheezing, the possibility of a foreign body must be actively excluded.
Upper Airway Cough Syndrome
Upper airway cough syndrome (UACS), formerly called postnasal drip syndrome, is one of the most common causes of chronic cough in childhood and can mimic cough-variant asthma. The cough is typically dry, worsens in the recumbent position, and may be accompanied by a sensation of throat dripping, frequent throat clearing, and posterior rhinorrhea.
Physical examination may reveal cobblestoning of the posterior pharyngeal wall (corrugated mucosa from lymphoid follicle hypertrophy). Spirometry is normal, and the cough improves with treatment of the underlying cause (allergic rhinitis, sinusitis). The coexistence of allergic rhinitis and asthma in up to 80% of cases reinforces the importance of otorhinolaryngologic assessment in children with asthma.
Treatment
Treatment follows a stepwise approach (step-up/step-down) according to the level of control. The goal is to achieve and maintain control with the lowest effective medication dose, minimizing side effects.
Education and Environmental Control
Teach correct inhaler technique (with spacer/valved holding chamber), written action plan for flares, allergen control (anti-dust-mite covers, environmental hygiene), avoidance of secondhand tobacco smoke exposure.
Step 1 — Reliever (intermittent asthma)
Inhaled salbutamol (short-acting bronchodilator) as needed for sporadic symptoms. If used more than 2x/week, step up.
Step 2-3 — Controller (persistent asthma)
Low-dose ICS (beclomethasone, fluticasone) as maintenance treatment. If insufficient: increase dose or add a leukotriene receptor antagonist (montelukast — note the FDA 2020 boxed warning for neuropsychiatric events: nightmares, agitation, mood changes, suicidal ideation) or LABA (formoterol; contraindicated in children <5 years per pediatric GINA 2023 — in this age group, escalate ICS rather than adding LABA).
Step 4-5 — Severe Asthma
Medium-to-high dose ICS + LABA (only in children ≥5 years; in <5 years prefer high-dose ICS and/or tiotropium per specialist guidance). Mandatory referral to a pediatric pulmonologist. Consider biologics (omalizumab, mepolizumab) in uncontrolled severe asthma.
Acupuncture as Treatment
Acupuncture is being investigated as a complementary therapy in pediatric asthma, focusing on possible modulation of the immune response and the bronchial autonomic nervous system. Systematic reviews suggest potential adjuvant benefit on quality of life; the impact on exacerbation frequency and pulmonary function remains heterogeneous and demands higher-quality pediatric trials.
Proposed mechanisms — supported mainly by preclinical studies — include possible modulation of the Th1/Th2 balance, of bronchial tone via vagal stimulation, of pro-inflammatory cytokines (IL-4, IL-5, IL-13), and of the hypothalamic-pituitary-adrenal axis. Consistent clinical translation in pediatrics has not yet been established.
In pediatric practice, traditional needles can be used in older children who cooperate, but we prioritize needle-free alternatives that are gentle, effective, and far better accepted by children with asthma.
Prognosis
The prognosis of pediatric asthma varies by phenotype. Early transient wheezers have an excellent prognosis — 50-60% will be asymptomatic by age 6. Children with persistent atopic asthma have a higher likelihood of maintaining asthma into adolescence and adulthood.
Factors associated with persistence include: early allergic sensitization, family history of asthma, eczema in childhood, reduced pulmonary function, and frequent severe wheezing episodes. Even in persistent asthma, adequate control with maintenance treatment allows a normal quality of life.
The most important message is that asthma is not a sentence of limitation. Olympic athletes, elite professionals, and millions of people live fully with well-controlled asthma. Adequate treatment is the key.
Myths and Facts
Myth vs. Fact
A child with asthma cannot play sports
With well-controlled asthma, children can and should engage in physical activity normally. Exercise improves cardiorespiratory capacity and may reduce symptoms long-term. A bronchodilator before exercise prevents exercise-induced asthma.
Asthma inhalers are addictive
Bronchodilators do not cause dependence. If a child is using one very frequently (more than 2x/week), it does not mean addiction — it means the asthma is not controlled and the preventive treatment needs adjustment.
Inhaled corticosteroids stunt growth
At low to moderate doses, the impact on growth is minimal (0.5-1 cm in the first year) and does not compromise final adult height. The risk of uncontrolled asthma is far greater than the risk of inhaled corticosteroids.
The child will outgrow asthma
Some phenotypes improve with age, but persistent atopic asthma often continues into adulthood. Adequate treatment in childhood prevents bronchial remodeling and protects future pulmonary function.
When to Seek Care
Early recognition of signs of poor control and severe flares is fundamental to the safety of the child.
Frequently Asked Questions
There is no definitive cure for asthma, but most children achieve full symptom control with appropriate treatment. Some phenotypes, especially the early transient wheezer, may resolve spontaneously. With correct treatment, the child can have a fully normal life.
Yes, and they should! With controlled asthma, physical activity is not only allowed but encouraged. Exercise improves cardiorespiratory capacity. When needed, the physician may recommend a bronchodilator before activity to prevent exercise-induced asthma.
At low to moderate doses, the impact is minimal (estimated at 0.5 cm in the first year) and does not compromise final adult height. The risk of uncontrolled asthma — with frequent exacerbations and oral corticosteroid use — is far greater than the risk of low-dose inhaled corticosteroids.
Acupuncture can be used as a complementary therapy — never as a substitute for conventional medical treatment. In pediatrics, the medical acupuncturist has needle-free alternatives that are very well accepted by children: laser acupuncture, auriculotherapy with seeds, and pediatric tuina. Needles can be used in cooperative children under medical guidance.
No. Bronchodilators do not cause pharmacological dependence. If a child needs the inhaler very frequently, it indicates that the asthma is not adequately controlled and the preventive treatment needs adjustment by the physician.
Warning signs of a severe flare include: marked breathing difficulty with intercostal retraction, blue lips or nails (cyanosis), inability to speak in full sentences, no response to the bronchodilator, drowsiness or confusion during the flare. In these cases, take the child to the emergency department immediately.
Yes, often. Viral respiratory infections, more common in autumn/winter, are the main trigger of exacerbations in pediatric asthma. Cold, dry air can also provoke bronchospasm. The spring-summer period can be difficult for children with allergic asthma because of pollen.
If the child is sensitized to animal dander/proteins (confirmed by allergy testing), removal of the animal is recommended by the physician. Although it is a difficult decision, reducing the allergen burden may significantly improve asthma control. The physician will assess the need for this measure on an individual basis.
No. The early transient wheezer phenotype usually resolves before age 6. Children with persistent atopic asthma have a higher likelihood of maintaining the disease into adolescence and adulthood, but many improve significantly. Adequate treatment in childhood protects future pulmonary function.
Medical acupuncture may be considered as an adjuvant to conventional treatment. The proposed mechanisms — immune modulation (Th1/Th2), of pro-inflammatory cytokines, and of bronchial tone via the autonomic nervous system — are based mainly on preclinical studies. Clinical pediatric evidence is more consistent for improvement in quality of life than for objective reduction of exacerbations. Always coordinated with the medical team, never replacing the primary treatment.
Related Reading
Deepen your knowledge with related articles